NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Xeptiva Therapeutics

Xeptiva Therapeutics

Private
MontevideoHealthcare & Life Scienceshttps://www.xeptiva.com/

Last Round

Seed

Oct 1, 2024

Total Funding Raised

$2.5M

Company Overview

Xeptiva Therapeutics is a biotechnology company that develops therapeutic vaccines for chronic inflammatory conditions in companion animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

therapeutic vaccinesimmunotherapy for animalscompanion animal healthveterinary biotechveterinary therapeuticsanimal healthcanine arthritis treatmentcanine atopic dermatitisclinical stage biotechchronic inflammatory diseasedrug discoveryequine healthfeline healthbiomarker discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xeptiva Therapeutics Comparables

Compare Xeptiva Therapeutics with similar companies based on industry and business-model similarity.

Xeptiva Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Xeptiva Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 1, 2024

Key People

Founding team and executive leadership

Josefina Correa

Chief Executive Officer

Executive Team

Xeptiva Therapeutics Investors

Notable investors and investment history

Xeptiva Therapeutics investors
InvestorRounds
Zentynel Frontier InvestmentsSeed
Fen VenturesSeed
ND LatamSeed
iThink VCSeed

Xeptiva Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xeptiva Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xeptiva Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontevideo
Employee Range9
Year Founded2021
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.